Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Ruffion

Showing results (181-190 of 218) with videos related to

Pageof 22
Sort By:
Urologic Oncology|February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinomaGéraldine Pignot, Pierre Colin, Marc Zerbib, et al.
World Journal of Urology|July 2, 2013
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomyPierre Colin, Tarek P Ghoneim, Laurent Nison, et al.
Annals of Surgical Oncology|July 31, 2012
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survivalPierre Colin, Adil Ouzzane, David R Yates, et al.
BJU International|May 9, 2013
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomySophie Hurel, Morgan Rouprêt, Adil Ouzzane, et al.
Neurourology and Urodynamics|March 7, 2024
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivityCamille Mailho, Benoit Peyronnet, Marianne De Seze, et al.
Urology|March 31, 2019
Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX StudyFloriane Michel, Carine Ciceron, Benjamin Bernuz, et al.
BJU International|June 19, 2012
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification toolFrançois Audenet, Pierre Colin, David R Yates, et al.
World Journal of Urology|October 17, 2012
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative databaseLaurent Nison, Morgan Rouprêt, Grégory Bozzini, et al.
Cancers|September 10, 2021
Biomarker in Active Surveillance for Prostate Cancer: A Systematic ReviewCécile Manceau, Gaëlle Fromont, Jean-Baptiste Beauval, et al.
European Urology|June 14, 2011
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Evanguelos Xylinas, et al.
Pageof 22

Showing results (181-190 of 218) with videos related to

Sort By:
Pageof 22
Urologic Oncology|February 14, 2013
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinomaGéraldine Pignot, Pierre Colin, Marc Zerbib, et al.
World Journal of Urology|July 2, 2013
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomyPierre Colin, Tarek P Ghoneim, Laurent Nison, et al.
Annals of Surgical Oncology|July 31, 2012
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survivalPierre Colin, Adil Ouzzane, David R Yates, et al.
BJU International|May 9, 2013
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomySophie Hurel, Morgan Rouprêt, Adil Ouzzane, et al.
Neurourology and Urodynamics|March 7, 2024
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivityCamille Mailho, Benoit Peyronnet, Marianne De Seze, et al.
Urology|March 31, 2019
Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX StudyFloriane Michel, Carine Ciceron, Benjamin Bernuz, et al.
BJU International|June 19, 2012
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification toolFrançois Audenet, Pierre Colin, David R Yates, et al.
World Journal of Urology|October 17, 2012
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative databaseLaurent Nison, Morgan Rouprêt, Grégory Bozzini, et al.
Cancers|September 10, 2021
Biomarker in Active Surveillance for Prostate Cancer: A Systematic ReviewCécile Manceau, Gaëlle Fromont, Jean-Baptiste Beauval, et al.
European Urology|June 14, 2011
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomyAdil Ouzzane, Pierre Colin, Evanguelos Xylinas, et al.
Pageof 22